| BioBay Investor Forum 2009 - Detailed Agenda |
| Monday, August 24, 2009 |
| 17:30 - 19:30 |
Welcome Reception - Hosted by BioBay
Meet with speakers and other attendees at this informal reception |
Suzhou Xi’an Jiaotong-Liverpool International Conference Center |
| Day 1 - Tuesday, August 25, 2009 |
| Time |
Title/Description |
Speakers |
| 08:00 - 09:00 |
Registration and Refreshments |
|
| 09:00 - 09:30 |
Welcome Remarks |
Greg Scott - President & Founder, ChinaBio® LLC |
| Yuwen Liu, MBA - General Manager, BioBay |
| 09:30 - 10:00 |
Keynote 1: The State of China's Biotech Industry
China's life science industry is moving quickly from services to innovation. Hear the latest update on novel technology development, investment, M&A and partnering deals, and other data from ChinaBio's research team. |
Greg Scott - President & Founder, ChinaBio® LLC |
| 10:00 - 10:30 |
Keynote 2: History and Success Factors for Life Science Clusters
Since the emergence of Silicon Valley, national and regional governments around the world have spent billions of dollars attempting to create similarly successful high-tech or life science clusters. Most of these have failed to provide the expected return on investment, while a few are emerging as potential successes. What are the factors that determine the success and sustainability of such clusters, and what can Suzhou do to ensure BioBay is in the successful minority? |
Charles Hsu, PhD, MBA - Venture Partner, Bay City Capital |
| 10:30 - 11:00 |
Networking Break and Refreshments |
|
| 11:00 - 12:00 |
Panel 1: Growing a Global BioBusiness in Suzhou
There are many challenges to building a global life science business, regardless of location. Learn how Suzhou supports emerging and established biotech/nanotech companies through government policies and incentives, funding, human resources, research laboratories, support services, etc. |
Moderator:
Kewen Jin, PhD - General Manager, Charles River Greater China |
Panelists:
Yuwen Liu, MBA - General Manager, BioBay |
| Philip Xiao, MBA - Co-Founder and Chief Development Officer, Profex Inc. |
| Tao Xiong, JD - Partner, Broad & Bright |
| John Zhu, PhD, MBA - Executive Director, Mingly China Growth Fund |
| |
| 12:00 - 13:30 |
Luncheon |
|
| 13:30 - 14:30 |
Panel 2: R&D Partnerships in China - Beyond Cost Savings
Many companies are coming to China seeking partnerships to speed product development. Major pharmaceutical companies and Contract Research Organizations (CROs) are actively seeking opportunities to work with China companies and researchers developing novel technologies. Hear industry executives define how to partner with them to move new biomedical technologies forward. |
Moderator:
Timothy Wong, PhD - Market Development Manager, Drug Discovery, Pharma and CRO, Asia Pacific, Invitrogen, part of Life Technologies |
Panelists:
Wen Chen, MBA - VP, Business Development, Tigermed Consulting Ltd. |
| Alex Fowkes, JD - Executive Director, Head of R&D Business Development, Pfizer Global Research & Development |
| Jennifer Hu, PhD - Director of Licensing & External Research, Merck & Co., Inc., USA |
| Stella Xu, PhD - Global Licensing Director, Roche Global Pharma Partnering |
| 14:30 - 17:00 |
Company Presentations |
8 companies (Two Tracks) |
| 17:00 - 18:00 |
BioBay Tour / Shuttle Bus to Banquet |
|
| 18:00 - 20:00 |
Gala Banquet - Scholars Hotel |
Sponsored by The Balloch Group |
| Day 2 - Wednesday, August 26, 2009 |
| Time |
Title/Description |
Speakers |
| 08:00 - 09:00 |
Registration and Refreshments |
|
| 09:00 - 09:30 |
Plenary: Navigating the SFDA - Getting Approvals in China
Many assume that drug approvals are easier and faster in China, but then learn that the process of getting new drugs to the clinic and ultimately to market has unique challenges that can slow or even deter the process. Learn how using the right approach can minimize unnecessary delays and optimize the probability of approval. |
Maria Song, PhD, MD - President, VPS-CRO Group |
| 09:30 - 10:30 |
Panel 3: Funding Growth in Challenging Times
The funding environment has changed dramatically in the last year of global economic turmoil. This panel explores how to raise funding from VCs and other sources, including some unique opportunities found only in China.
|
Moderator:
Charles C. Comey, JD - Managing Partner, Morrison & Foerster |
Panelists:
Wayne Li, PhD - Moringside |
| William Li, MBA - Partner, Ginko Partners Ltd |
| Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed Asia |
| Yanning Yi, MBA - Vice President, The Balloch Group |
| |
| 10:30 - 11:00 |
Break and Refreshments |
|
| 11:00 - 12:00 |
Panel 4: Suzhou Success Stories - From Local to Global
Senior executives who are building successful life science companies in Suzhou tell how they went from startup to growth to global status and the challenges they faced along the way. |
Moderator:
Wei Zhou, PhD, JD – Partner, Wilson Sonsini Goodrich & Rosati |
Panelists:
John Li - President and CEO, HOB Biotech Group |
| Jimmy Wei, PhD, MBA - Vice Presient, Business Development, Hutchison MediPharma |
| Michael Xu, MD, PhD - CEO, PegBio Co., Ltd. |
| Peter Zhang, PhD - Chairman & CEO, Suzhou GenePharma Co., Ltd. |
|
| 12:00 - 13:30 |
Luncheon |
|
| 13:30 - 16:00 |
Company Presentations |
8 companies (Two Tracks) |
| 16:00 - 16:30 |
Raffle Drawings - Win valuable prizes |
|
| 16:30 - 17:00 |
Award Ceremony / Closing Remarks |
Sponsored by Unitalen Attorneys at Law |
_1241426952.jpg)
